Global Veterinary Immunodiagnostics Market Size By Type (Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay), By Application (Cattle, Pigs), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Immunodiagnostics Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2023–2031). This growth is attributed to the increasing prevalence of zoonotic diseases, the rising adoption of companion animals, and the surge in demand for accurate and early disease diagnostics in veterinary settings. Immunodiagnostic tools play a pivotal role in animal healthcare by enabling the timely detection of infections, hormonal disorders, and autoimmune diseases, thereby ensuring effective treatment outcomes and disease control measures.

Drivers:

1. Rising Incidence of Zoonotic and Infectious Diseases:

Veterinary immunodiagnostics are essential in managing zoonotic threats like rabies, leptospirosis, and avian influenza. The growing awareness of animal-to-human disease transmission is compelling veterinary clinics and livestock farmers to adopt rapid diagnostic solutions.

2. Growth in Companion Animal Ownership and Pet Healthcare Spending:

Increasing pet adoption and the humanization of pets have led to higher spending on veterinary services, including diagnostics. Immunodiagnostic kits enable veterinarians to detect chronic and acute conditions early, supporting the trend of preventive care.

3. Technological Advancements in Immunoassay Platforms:

The development of user-friendly, automated, and portable immunodiagnostic systems has significantly improved diagnostic accuracy and efficiency. Technologies like ELISA, lateral flow assays, and chemiluminescence immunoassays are gaining traction in both clinics and field applications.

Restraints:

1. High Cost of Advanced Diagnostic Kits and Instruments:

The high upfront costs associated with advanced immunodiagnostic platforms can be a barrier, especially for small clinics and practices in low-income regions. Maintenance and calibration costs further contribute to the financial burden.

2. Lack of Standardization in Diagnostic Procedures:

The absence of consistent diagnostic protocols and reagent quality across different regions and labs may result in variability and inaccuracies in results, affecting the credibility of immunodiagnostic solutions.

Opportunity:

1. Expansion of Livestock Healthcare in Emerging Markets:

Countries in Asia-Pacific and Africa are increasingly investing in livestock health programs to improve food security. This opens up lucrative opportunities for immunodiagnostic kit manufacturers to supply affordable and scalable testing solutions.

2. Integration of Artificial Intelligence in Diagnostic Workflows:

AI-enabled immunodiagnostic platforms that enhance result interpretation, reduce errors, and provide decision support to veterinarians are expected to revolutionize veterinary diagnostics.

3. Growing Demand for Point-of-Care Testing:

On-site rapid testing solutions for diseases like parvovirus, brucellosis, and FMD (foot-and-mouth disease) are gaining popularity among veterinarians and livestock owners, particularly in rural and mobile veterinary units.

Market by System Type Insights:

The ELISA-based immunodiagnostics segment accounted for the largest share in 2023, owing to its high specificity, cost-effectiveness, and widespread application in both companion and livestock animals. However, the lateral flow assays (LFA) segment is expected to register the fastest growth during the forecast period due to their suitability for point-of-care and rapid testing environments.

Market by End-use Insights:

In terms of end-use, veterinary reference laboratories dominated the market in 2023, benefiting from increased sample volumes, advanced infrastructure, and skilled personnel. However, point-of-care settings and veterinary clinics are anticipated to witness accelerated growth due to the demand for decentralized and quick diagnostics, especially in rural and mobile care setups.

Market by Regional Insights:

North America led the market in 2023, driven by strong veterinary infrastructure, high pet ownership, and technological adoption. Europe followed closely, supported by stringent animal welfare regulations. Asia-Pacific is forecasted to experience the highest CAGR through 2031, propelled by government-led animal health programs, growing livestock population, and increasing awareness of animal diagnostics in countries like India and China.

Competitive Scenario:

Key players operating in the Global Veterinary Immunodiagnostics Market include:

IDEXX Laboratories, Inc.

Zoetis Inc.

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

Neogen Corporation

Virbac

Randox Laboratories Ltd.

Heska Corporation

IDvet

Bionote Inc.

These companies are focusing on the development of multiplex diagnostic kits, strategic collaborations with veterinary hospitals, and global expansion into emerging markets to enhance their market footprint.

Scope of Work – Global Veterinary Immunodiagnostics Market

Report Metric Details

Market Size (2023) USD 2.1 Billion

Projected Market Size (2031) USD 4.3 Billion

CAGR (2023–2031) 9.2%

Market Segments System Type (ELISA, LFA, CLIA), End-use (Clinics, Labs)

Growth Drivers Rise in zoonotic diseases, companion animal care, technological innovation

Opportunities Emerging markets, point-of-care diagnostics, AI integration

Key Market Developments:

2023: IDEXX Laboratories launched a next-generation ELISA panel that enables early detection of vector-borne diseases in dogs and cats.

2024: Zoetis acquired a leading European veterinary diagnostics firm to strengthen its market reach and expand its product portfolio.

2025: Thermo Fisher Scientific announced AI-powered cloud diagnostics software integrated into its veterinary immunoassay analyzers, offering real-time analytics and veterinary decision support.

FAQs:

1) What is the current market size of the Global Veterinary Immunodiagnostics Market?

The market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Veterinary Immunodiagnostics Market?

The rising prevalence of zoonotic diseases and increasing pet care spending are key growth drivers.

3) Which is the largest region during the forecast period in the Global Veterinary Immunodiagnostics Market?

North America is projected to maintain dominance, while Asia-Pacific is expected to witness the highest growth.

4) Which segment accounted for the largest market share in the Global Veterinary Immunodiagnostics Market?

The ELISA-based immunodiagnostics segment held the largest share in 2023.

5) Who are the key market players in the Global Veterinary Immunodiagnostics Market?

Key players include IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Bio-Rad, and Neogen Corporation.